Over the past 15 years the incidence of hepatocellular carcinoma [HCC] has more than doubled. Every year there are 500,000 new cases
in the AsiaâPacific region, often due to chronic hepatitis B virus [HBV] infection. More than 60% of the total number of HCC cases
occurs in China alone and an estimated 360,000 patients residing in Far East countries, including China, Japan, Korea and Taiwan, die
from this disease each year. In Japan hepatitis C virus [HCV]-related HCC represents 70% of all cases. In addition, in the USA and
Europe, an increased incidence of HCV has led to an increased incidence of HCC. A relevant risk factor for the high incidence of
nonalcoholic fatty liver disease is obesity and diabetes, which can promote the development of liver cancer. This involves a poor
diagnosis and a low level of survival year survival rate: less than 5%] in patients with advanced HCC at diagnosis.
Last date updated on September, 2020